RE:MRNA-WHERE ARE ALL THE KNOW IT ALLS WHO JUMPED DOWN MY THROAT FROM 2 YEARS
AGO?
FROM $20 DOLLARS TO $.26 CENTS NOW!
update:01/23/09 After two years of posting accurately on this site and many
others, and scoring the highest on motely fool since march 2007, here is an
update by minyanville.
http://www.minyanville.com/articles/index.php?a=20780

MINYANVILLE
Biotech Roundup: Judgment Day for Dendreon;
Just Say No to Pfizer-Wyeth Combo
David Miller Jan 23, 2009 2:30 pm

MDRNA/Nastech 

Over the last year or so I’ve been cautioning investors on
MDRNA (MRNA),
formerly known as Nastech. Word today from Luke Timmerman at Xconomy is that the
company
is about done. They’ve cut executive pay and frozen salaries. They’re about
to be delisted.
When their nasal drug development effort predictably cratered, they didn’t
aggressively cut cash
fast enough to give themselves enough run time to get their mRNA platform
advanced.

I can’t say enough how much management matters. About 5-10% of
the time a company’s product
or technology can overcome management mistakes. The rest of the time investors
get burned.
It’s a lesson all of us who invest in the space find ourselves relearning
from time-to-time